Concepedia

KENNETH W. OLANDER

KW

Statistics

Publications

1

Citations

18

H-Index

1

Active since

2004

Affiliations

Pfizer (United Kingdom)(Current)

KENNETH W. OLANDER is an author at Pfizer (United Kingdom) specializing in ocular disease, ocular hypertension treatment, and glaucoma-related vision loss.

Publications per year

2004–2004

1

Publications

1

Switching from latanoprost to fixed-combination latanoprost-timolol: a 2I -day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension

KENNETH W. OLANDER, Thomas Zimmerman, Noreen Downes et al. · Clinical Therapeutics · 2004 · 18 citations

Health Professions, Ophthalmology, Pharmacotherapy +11

1–1 of 1